CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-04-08 | JORDEN DAVID EMERSON Director | Purchase | +43,485 | $0.51 | $22K | 6,793,485 |
| 2013-04-04 | ROSENDALE MARTIN P Chief Executive Officer | Purchase | +17,231 | $0.52 | $9K | 204,149 |
| 2013-03-19 | Kent Richard S Director | Grant or award · Option to purchase shares of Common Stock | +30,000 | 30,000 | ||
| 2013-03-19 | WINZER C ERIC Director | Grant or award · Option to purchase shares of Common Stock | +40,000 | 200,000 | ||
| 2013-03-19 | DEL GUERCIO JOSEPH Director | Grant or award · Option to purchase shares of Common Stock | +30,000 | 580,362 | ||
| 2013-03-19 | HOHNKE LYLE A Director | Grant or award · Option to purchase shares of Common Stock | +30,000 | 535,000 | ||
| 2013-03-19 | McLoughlin Mark T Director | Grant or award · Option to purchase shares of Common Stock | +40,000 | 390,000 | ||
| 2013-03-19 | Benson James Director | Grant or award · Option to purchase shares of Common Stock | +30,000 | 380,000 | ||
| 2013-03-19 | KEITH STEPHEN Director | Grant or award · Option to purchase shares of Common Stock | +40,000 | 200,000 | ||
| 2013-02-27 | JORDEN DAVID EMERSON Director | Purchase | +4,400 | $0.53 | $2K | 6,750,000 |
| 2013-02-26 | JORDEN DAVID EMERSON Director | Purchase | +20,600 | $0.52 | $11K | 6,745,600 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +22,308 | $0.55 | $12K | 108,830 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +32,238 | $0.55 | $18K | 157,276 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +90,909 | $0.55 | $50K | 175,533 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +90,909 | $0.55 | $50K | 429,404 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +18,182 | $0.55 | $10K | 60,494 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase | +27,273 | $0.55 | $15K | 39,967 |
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +15,616 | 15,616 | ||
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +22,567 | 22,567 | ||
| 2013-02-22 | Aldagen Holdings, LLC 10% owner | Purchase · Warrant (right to buy) | +63,636 | 63,636 |
Page 11 of 22 · 436 trades